DK3562485T3 - Ikke-hormonale sammensætninger og fremgangsmåder til mandlig kontraception omfattende (r)-silodosin - Google Patents
Ikke-hormonale sammensætninger og fremgangsmåder til mandlig kontraception omfattende (r)-silodosin Download PDFInfo
- Publication number
- DK3562485T3 DK3562485T3 DK19714150.0T DK19714150T DK3562485T3 DK 3562485 T3 DK3562485 T3 DK 3562485T3 DK 19714150 T DK19714150 T DK 19714150T DK 3562485 T3 DK3562485 T3 DK 3562485T3
- Authority
- DK
- Denmark
- Prior art keywords
- silodosin
- procedures
- male contraception
- hormonal compositions
- contraception including
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
- A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/16—Masculine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Reproductive Health (AREA)
- Endocrinology (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862763129P | 2018-03-23 | 2018-03-23 | |
| EP18305328 | 2018-03-23 | ||
| PCT/EP2019/057267 WO2019180217A1 (en) | 2018-03-23 | 2019-03-22 | Non-hormonal compositions and methods for male contraception |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK3562485T3 true DK3562485T3 (da) | 2020-08-24 |
Family
ID=65955198
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK19714150.0T DK3562485T3 (da) | 2018-03-23 | 2019-03-22 | Ikke-hormonale sammensætninger og fremgangsmåder til mandlig kontraception omfattende (r)-silodosin |
Country Status (17)
| Country | Link |
|---|---|
| US (3) | US10912762B2 (da) |
| EP (2) | EP3750538A1 (da) |
| JP (1) | JP7270901B2 (da) |
| KR (1) | KR102496504B1 (da) |
| CN (1) | CN112074269A (da) |
| AU (1) | AU2019237228B2 (da) |
| BR (1) | BR112020018925A2 (da) |
| CA (1) | CA3094016C (da) |
| DK (1) | DK3562485T3 (da) |
| ES (1) | ES2813084T3 (da) |
| IL (1) | IL277372B2 (da) |
| MA (1) | MA53626A (da) |
| MX (1) | MX2020009937A (da) |
| PL (1) | PL3562485T3 (da) |
| PT (1) | PT3562485T (da) |
| SG (1) | SG11202008794TA (da) |
| WO (1) | WO2019180217A1 (da) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SG11202008794TA (en) * | 2018-03-23 | 2020-10-29 | Laboratoires Major | Non-hormonal compositions and methods for male contraception |
| US20240180871A1 (en) * | 2022-11-23 | 2024-06-06 | Pharmajor Incorporated | Modified-release silodosin compositions and use thereof in methods for male contraception |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US1091276A (en) | 1911-12-09 | 1914-03-24 | Basf Ag | Producing unsaturated terpene hydrocarbons. |
| US4210644A (en) | 1978-02-23 | 1980-07-01 | The Johns Hopkins University | Male contraception |
| DE4308406C1 (de) | 1993-03-12 | 1994-06-16 | Jenapharm Gmbh | Kombinationspräparat zur Kontrazeption |
| ATE355844T1 (de) | 2000-02-15 | 2007-03-15 | Schering Ag | Zusammensetzung zur männlichen kontrazeption, norethisteron und testosteron undecanoat enthaltend |
| FR2861990B1 (fr) * | 2003-11-10 | 2006-02-10 | Nouveaux Produits Pharma | Comprimes faiblement doses a reseau de polymeres |
| CN101316934A (zh) * | 2005-09-29 | 2008-12-03 | 拜耳医药保健股份公司 | 用于治疗泌尿系统疾病的pde抑制剂及其组合 |
| EP1931797A2 (en) * | 2005-09-29 | 2008-06-18 | Bayer HealthCare AG | Pde inhibitors and combinations thereof for the treatment of urological disorders |
| KR20090094811A (ko) * | 2006-10-05 | 2009-09-08 | 파나세아 바이오테크 리미티드 | 새로운 형태의 주입형 데포조성물 및 이를 조제하기 위한 방법 |
| GB0700893D0 (en) | 2007-01-17 | 2007-02-21 | King S College London | Male contraceptive |
| MX2009009230A (es) * | 2007-02-28 | 2009-11-26 | Kissei Pharmaceutical | Uso de silodosina en una administracion diaria para tratar hiperplasia prostatica benigna. |
| US20120184591A1 (en) * | 2011-01-13 | 2012-07-19 | Watson Pharmaceuticals, Inc. | Methods for treating prostatitis |
| CN102283816B (zh) | 2011-08-05 | 2013-09-11 | 北京海步国际医药科技发展有限公司 | 西洛多辛缓释片剂及其制备方法 |
| WO2014118606A2 (en) * | 2013-01-29 | 2014-08-07 | Alembic Pharmaceuticals Limited | A novel process for the preparation of silodosin |
| WO2016051782A1 (ja) | 2014-09-30 | 2016-04-07 | キッセイ薬品工業株式会社 | 苦味を有する薬剤の苦味をマスキングした経口投与製剤 |
| US20170049834A1 (en) * | 2015-08-18 | 2017-02-23 | Golden Biotechnology Corporation | Benign prostatic hyperplasia add-on therapy |
| SG11202008794TA (en) * | 2018-03-23 | 2020-10-29 | Laboratoires Major | Non-hormonal compositions and methods for male contraception |
-
2019
- 2019-03-22 SG SG11202008794TA patent/SG11202008794TA/en unknown
- 2019-03-22 WO PCT/EP2019/057267 patent/WO2019180217A1/en active Application Filing
- 2019-03-22 US US16/362,081 patent/US10912762B2/en active Active
- 2019-03-22 EP EP20182691.4A patent/EP3750538A1/en active Pending
- 2019-03-22 AU AU2019237228A patent/AU2019237228B2/en active Active
- 2019-03-22 PL PL19714150T patent/PL3562485T3/pl unknown
- 2019-03-22 IL IL277372A patent/IL277372B2/en unknown
- 2019-03-22 JP JP2021500350A patent/JP7270901B2/ja active Active
- 2019-03-22 ES ES19714150T patent/ES2813084T3/es active Active
- 2019-03-22 BR BR112020018925-1A patent/BR112020018925A2/pt unknown
- 2019-03-22 DK DK19714150.0T patent/DK3562485T3/da active
- 2019-03-22 CA CA3094016A patent/CA3094016C/en active Active
- 2019-03-22 MA MA053626A patent/MA53626A/fr unknown
- 2019-03-22 KR KR1020207029031A patent/KR102496504B1/ko active IP Right Grant
- 2019-03-22 PT PT197141500T patent/PT3562485T/pt unknown
- 2019-03-22 CN CN201980030077.4A patent/CN112074269A/zh active Pending
- 2019-03-22 MX MX2020009937A patent/MX2020009937A/es unknown
- 2019-03-22 EP EP19714150.0A patent/EP3562485B8/en active Active
-
2020
- 2020-12-30 US US17/137,747 patent/US11583518B2/en active Active
-
2023
- 2023-01-06 US US18/093,940 patent/US11951095B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| IL277372B2 (en) | 2023-09-01 |
| US20230145374A1 (en) | 2023-05-11 |
| US11583518B2 (en) | 2023-02-21 |
| EP3562485B1 (en) | 2020-07-01 |
| US20210113526A1 (en) | 2021-04-22 |
| PL3562485T3 (pl) | 2020-11-16 |
| EP3562485A1 (en) | 2019-11-06 |
| CN112074269A (zh) | 2020-12-11 |
| IL277372B1 (en) | 2023-05-01 |
| SG11202008794TA (en) | 2020-10-29 |
| MX2020009937A (es) | 2022-09-30 |
| US20190290615A1 (en) | 2019-09-26 |
| EP3750538A1 (en) | 2020-12-16 |
| AU2019237228B2 (en) | 2023-06-08 |
| EP3562485B8 (en) | 2020-08-19 |
| IL277372A (en) | 2020-11-30 |
| CA3094016C (en) | 2023-10-10 |
| JP7270901B2 (ja) | 2023-05-11 |
| RU2020134408A3 (da) | 2022-04-29 |
| KR20200135978A (ko) | 2020-12-04 |
| KR102496504B1 (ko) | 2023-02-06 |
| AU2019237228A1 (en) | 2020-10-01 |
| ES2813084T3 (es) | 2021-03-22 |
| PT3562485T (pt) | 2020-08-27 |
| US11951095B2 (en) | 2024-04-09 |
| US10912762B2 (en) | 2021-02-09 |
| WO2019180217A1 (en) | 2019-09-26 |
| MA53626A (fr) | 2022-03-09 |
| BR112020018925A2 (pt) | 2020-12-29 |
| CA3094016A1 (en) | 2019-09-26 |
| RU2020134408A (ru) | 2022-04-29 |
| JP2021518438A (ja) | 2021-08-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK3565550T3 (da) | Farmaceutiske sammensætninger omfattende meloxicam og rizatriptan | |
| DK4206298T3 (da) | Stabiliserede fluorolefinsammensætninger og fremgangsmåde til fremstilling, oplagring og anvendelse deraf | |
| DK3518933T3 (da) | Fremgangsmåder til behandling af uterusfibromer og endometriose | |
| DK3442973T3 (da) | Hidtil ukendte forbindelser som autotaxinhæmmere og farmaceutiske sammensætninger omfattende samme | |
| DK3286181T3 (da) | Pyrazolforbindelser og fremgangsmåde til fremstilling og anvendelse af forbindelserne | |
| DK3430038T3 (da) | Sammensætninger og fremgangsmåder til cd20-immunterapi | |
| DK3592337T3 (da) | Farmaceutiske formuleringer af phloroglucinol og trimethylphloroglucinol | |
| DK3574135T3 (da) | Fremgangsmåde og formulering til fremstilling af ligninfibre | |
| DK3102184T3 (da) | Stabile formuleringer af peptider og fremgangsmåder til fremstilling | |
| DK3874813T3 (da) | Mobilitetsprocedure | |
| DK3081263T3 (da) | Sammensætninger og redskaber til behandling af glaukom | |
| DK3855919T3 (da) | Sammensætninger med bacillus amyloliquefaciens fcc1256 og fremgangsmåder til bekæmpelse af plantepatogener | |
| DK3695103T3 (da) | Anordning og fremgangsmåde til køling | |
| DK3458650T3 (da) | Fremgangsmåde til desinficering og vandhaneforbindelsesarrangement dertil | |
| DK3618772T3 (da) | Form og fremgangsmåde til fremstilling af en ortopædisk spacer af medicinsk cement | |
| DK3517083T3 (da) | Høreværnssystem og relateret fremgangsmåde | |
| DK3522873T3 (da) | Sammensætninger og fremgangsmåder til behandlingen af xerostomi | |
| DK3735228T3 (da) | Programmerbar farmaceutiske sammensætninger til krono-lægemiddelfrigivelse | |
| DK3599810T3 (da) | System og fremgangsmåde til jordforarbejdning | |
| DK3721718T3 (da) | Trelagskapsel bestående af ikke-hydrogeneret fedt, og fremgangsmåde til fremstilling deraf | |
| DK3717706T3 (da) | Indretning og fremgangsmåde til at hæve nedgravede rør | |
| DK3562485T3 (da) | Ikke-hormonale sammensætninger og fremgangsmåder til mandlig kontraception omfattende (r)-silodosin | |
| DK3354955T3 (da) | Rørkobling og koblingsfremgangsmåde | |
| DK3442944T3 (da) | Fremgangsmåde til fremstillingen af 4-aminoindanderivater og relaterede aminoindanamider | |
| DK3733177T3 (da) | Sammensætning til hornhindebeskyttelse |